• Why We Need Clinical Trials For Lymphoma
  • Innate to Present New Data from Therapy Candidate for Cutaneous T-Cell Lymphoma
  • Stem Cell Transplants May Not Extend Survival in DHL Patients in Remission, UPenn Study Suggests
  • Betalutin Trial for Non-Hodgkin’s Lymphoma Patients Opens New Expansion Cohort
  • DPX-Survivac to be Tested in Canada as Triple-combo Lymphoma Treatment
  • Dating and Cancer: My Journal Through It All
  • FDA Gives Copanlisib Priority Review for Treatment of Follicular Lymphoma
  • Lymphoma Patients with High-risk Mutation Respond Better to Imbruvica Than Those Without Mutation
  • Injected Rituxan Is as Effective and Safe as IV Form as Lymphoma Treatment, Study Concludes
  • Adding Etoposide Improves Survival in Middle-aged and Older Lymphoma Patients, Study Reports
  • Managed Access Program to Provide European Peripheral T-cell Lymphoma Patients Access to Beleodaq
  • A Thank-You Letter in Honor of National Nurses Week
  • Gexa Energy to Sponsor Leukemia & Lymphoma Society’s 2017 ‘Light The Night’ Walk in Houston